Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
CONMED
CNMD
CONMED
Rising Costs And Supply Risks Will Impair Future Performance
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
08 May 25
Updated
08 May 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$55.00
1.3% undervalued
intrinsic discount
08 May
US$54.28
1Y
-25.3%
7D
-0.4%
Loading
1Y
-25.3%
7D
-0.4%
Author's Valuation
US$55.0
1.3% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$55.0
1.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-94m
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.5b
Earnings US$127.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.55%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.64%
Calculation
US$127.40m
Earnings '28
x
16.88x
PE Ratio '28
=
US$2.15b
Market Cap '28
US$2.15b
Market Cap '28
/
31.36m
No. shares '28
=
US$68.57
Share Price '28
US$68.57
Share Price '28
Discounted to 2025 @ 8.04% p.a.
=
US$54.37
Fair Value '25
